← Back to Search

Financial Education for Young Adult Cancer Patients

N/A

Recruiting

Led By Melissa Beauchemin

Research Sponsored by Columbia University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 15 - 39 years old

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 6 months

Awards & highlights

Study Summary

This trial seeks to create a financial toxicity tool and an intervention to reduce financial burdens for young adult cancer patients. #AYACancer #FinancialToxicity

Who is the study for?

This trial is for young adults (ages 15-39) diagnosed with cancer within the last 18 months, and their caregivers who handle finances. Participants must speak English or Spanish and not be on hospice care. Those unable to complete financial surveys or with conditions that make participation unsafe are excluded.Check my eligibility

What is being tested?

The study aims to create a tool for measuring financial stress in young adult cancer patients and test an educational program designed to help manage the financial burden of cancer treatment. It involves adapting a measurement tool and piloting a novel financial education/navigation intervention.See study design

What are the potential side effects?

Since this trial focuses on education and navigation rather than medical treatments, traditional physical side effects are not expected. However, participants may experience emotional distress related to discussions about personal finances.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 15 and 39 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of (OR percentage of) participants who completed the intervention

Percentage of eligible participants who consented to be in study

Secondary outcome measures

Comprehensive Score of Financial Toxicity (COST measure)

Trial Design

1Treatment groups

Experimental Treatment

Group I: Patient Financial Education / NavigationExperimental Treatment1 Intervention

Individuals who screen positive will all move forward to receive the intervention. This intervention includes partnering with community-based organizations to deliver financial education, connection to resources, and counseling tailored to individual patients and spouses for 6-months.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor

1,433 Previous Clinical Trials

2,447,043 Total Patients Enrolled

Patient Advocate FoundationUNKNOWN

Melissa BeaucheminPrincipal InvestigatorColumbia University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies left in this research program for participants?

"It appears that the medical trial in question has stopped recruiting patients. The study was first presented on November 1st 2023 and its last update occurred three days ago, yet 17 other trials are still looking for volunteers."

Answered by AI